RxDoctor Payments Data

Victor Urrutia, MD

Neurology · Baltimore, MDNPI 1710930003

Payments from drug & device makers

What this record shows

That places this record below the midpoint for neurology clinicians in MD, where the typical reported total is $1,345.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$574,836in research payments, 2019–2025

Across 14 payments — averaging $41,060 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$571K
  • Boehringer Ingelheim$4K

How this compares

$0 in reported general payments places this provider in the 5th percentile of 442 neurology providers in Maryland.

See all neurology providers in Maryland

Medicare billing

Part B allowed, 2024
$29,941
Medicare patients
113
Services billed
216

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
QuliptaAtogepant19$28,201
Atorvastatin Calcium44$723
Sertraline Hcl21$426
Topiramate20$192
Tramadol Hcl15$174
Duloxetine Hcl16$173

Paid to pharmacies, not to this prescriber.

Other neurology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →